Page 1 of Clinical Trials for Philadelphia Chromosome-positive Chronic Myelocytic Leukemia, 120 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
Last Updated: August 26, 2009
Condition(s): Philadelphia Chromosome-positive Chronic Myelocytic Leukemia
2
Active, not recruiting
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
Last Updated: January 12, 2012
Condition(s): Chronic Myelogenous Leukemia
3
Recruiting
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Last Updated: June 22, 2011
Condition(s): Chronic Myelogenous Leukemia in Chronic Phase
4
Recruiting
Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia
Last Updated: June 4, 2011
Condition(s): Leukemia
5
Completed
Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
Last Updated: August 3, 2010
Condition(s): Chronic Myeloid Leukemia; Philadelphia-Positive Myeloid Leukemia
6
Active, not recruiting
Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Last Updated: October 22, 2011
Condition(s): Chronic Myelogenous Leukemia
7
Active, not recruiting
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Last Updated: January 27, 2010
Condition(s): Myelogenous Leukemia, Chronic
8
Not yet recruiting
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Last Updated: January 9, 2012
Condition(s): Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
9
Completed
A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
Last Updated: November 30, 2010
Condition(s): Myeloid Leukemia, Chronic
10
Active, not recruiting
A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Last Updated: January 1, 2012
Condition(s): Myelogenous Leukemia, Chronic
11
Recruiting
Clinical Trial of L-Grb-2 Antisense Oligonucleotide in CML, AML, ALL & MDS
Last Updated: July 8, 2010
Condition(s): Safety and Pharmacokinetics of L-Grb-2 in Treating CML, AML, CLL and MDS
12
Active, not recruiting
Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib
Last Updated: November 23, 2011
Condition(s): Chronic Myelogenous Leukemia - Chronic Phase
13
Active, not recruiting
A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML
Last Updated: February 2, 2012
Condition(s): Myeloid Leukemia, Chronic
14
Completed
Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)
Last Updated: January 20, 2012
Condition(s): Myelogenous Leukemia, Chronic
15
Completed
Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan
Last Updated: April 7, 2011
Condition(s): Chronic Myelogenous Leukemia
16
Completed
Study of BMS-354825 in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
Last Updated: August 3, 2010
Condition(s): Chronic Myeloid Leukemia; Philadelphia-Positive Myeloid Leukemia
17
Terminated
Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)
Last Updated: September 7, 2011
Condition(s): Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML); Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
18
Recruiting
Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response
Last Updated: January 31, 2012
Condition(s): Philadelphia Chromosome Positive; Chronic Myelogenous Leukemia in Chronic Phase
19
Recruiting
Determining the Maximum Tolerated Dose of Low Dose Interferon-alfa in Conjunction With Nilotinib in Imatinib Resistant and/or Intolerant Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)
Last Updated: July 26, 2011
Condition(s): Chronic Myeloid Leukemia
20
Completed
Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Last Updated: April 7, 2011
Condition(s): Chronic Myeloid Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-positive

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Philadelphia+Chromosome-positive+Chronic+Myelocytic+Leukemia

Page 1 of Clinical Trials for Philadelphia Chromosome-positive Chronic Myelocytic Leukemia, 120 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About